Olivia Ifeoma Okereke, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Depression | 57 | 2024 | 8126 | 3.820 |
Why?
|
Depressive Disorder | 16 | 2021 | 3728 | 2.330 |
Why?
|
Fatty Acids, Omega-3 | 7 | 2023 | 1390 | 2.170 |
Why?
|
Cognition | 32 | 2024 | 6992 | 1.980 |
Why?
|
Cognition Disorders | 24 | 2018 | 3980 | 1.970 |
Why?
|
Aging | 25 | 2024 | 8710 | 1.930 |
Why?
|
Cacao | 2 | 2024 | 98 | 1.670 |
Why?
|
Cholecalciferol | 6 | 2024 | 553 | 1.610 |
Why?
|
Phobic Disorders | 6 | 2018 | 439 | 1.560 |
Why?
|
Telomere | 5 | 2021 | 943 | 1.420 |
Why?
|
C-Peptide | 6 | 2012 | 440 | 1.380 |
Why?
|
Vitamins | 8 | 2024 | 1635 | 1.370 |
Why?
|
Caregivers | 5 | 2022 | 2238 | 1.250 |
Why?
|
Affect | 3 | 2021 | 1486 | 0.940 |
Why?
|
Leukocytes | 3 | 2018 | 2026 | 0.860 |
Why?
|
Vitamin D | 7 | 2023 | 3303 | 0.840 |
Why?
|
Nurses | 17 | 2024 | 2478 | 0.810 |
Why?
|
Alzheimer Disease | 12 | 2024 | 8601 | 0.810 |
Why?
|
Aged | 95 | 2024 | 169310 | 0.800 |
Why?
|
Apolipoprotein E4 | 3 | 2024 | 709 | 0.770 |
Why?
|
Dietary Supplements | 12 | 2024 | 3415 | 0.760 |
Why?
|
DNA Copy Number Variations | 2 | 2020 | 2020 | 0.730 |
Why?
|
Vitamin D Deficiency | 4 | 2020 | 1388 | 0.680 |
Why?
|
Neuropsychological Tests | 15 | 2024 | 7054 | 0.630 |
Why?
|
Double-Blind Method | 10 | 2024 | 12341 | 0.600 |
Why?
|
DNA, Mitochondrial | 2 | 2020 | 865 | 0.600 |
Why?
|
Depressive Disorder, Major | 4 | 2023 | 4762 | 0.570 |
Why?
|
Healthcare Disparities | 3 | 2022 | 3358 | 0.560 |
Why?
|
Life Style | 8 | 2024 | 3917 | 0.550 |
Why?
|
DNA Methylation | 2 | 2023 | 4399 | 0.550 |
Why?
|
Dementia | 7 | 2024 | 2689 | 0.540 |
Why?
|
Humans | 154 | 2024 | 761596 | 0.540 |
Why?
|
Amyloid beta-Peptides | 6 | 2015 | 3839 | 0.530 |
Why?
|
Antidepressive Agents | 14 | 2020 | 2897 | 0.520 |
Why?
|
Middle Aged | 90 | 2024 | 220921 | 0.520 |
Why?
|
Memory | 10 | 2019 | 2193 | 0.510 |
Why?
|
Female | 113 | 2024 | 392705 | 0.510 |
Why?
|
Anxiety | 8 | 2024 | 4573 | 0.500 |
Why?
|
Cross-Sectional Studies | 20 | 2024 | 26129 | 0.490 |
Why?
|
Bereavement | 1 | 2018 | 308 | 0.440 |
Why?
|
Prospective Studies | 47 | 2024 | 54423 | 0.440 |
Why?
|
Vitamin B 6 | 1 | 2015 | 234 | 0.440 |
Why?
|
Seafood | 2 | 2014 | 393 | 0.430 |
Why?
|
Flavonoids | 1 | 2016 | 445 | 0.430 |
Why?
|
Primary Prevention | 2 | 2020 | 1186 | 0.420 |
Why?
|
Patient Preference | 1 | 2020 | 927 | 0.400 |
Why?
|
Vitamin B 12 | 1 | 2015 | 524 | 0.390 |
Why?
|
Psychiatry | 1 | 2024 | 1693 | 0.380 |
Why?
|
Neoplasms, Glandular and Epithelial | 4 | 2016 | 487 | 0.380 |
Why?
|
Psychiatric Status Rating Scales | 6 | 2020 | 6019 | 0.370 |
Why?
|
Mental Health Services | 2 | 2022 | 1730 | 0.370 |
Why?
|
Diet, Mediterranean | 3 | 2013 | 740 | 0.350 |
Why?
|
Interviews as Topic | 4 | 2013 | 2696 | 0.340 |
Why?
|
Proportional Hazards Models | 15 | 2024 | 12463 | 0.340 |
Why?
|
Multifactorial Inheritance | 1 | 2018 | 1387 | 0.340 |
Why?
|
Mental Disorders | 4 | 2019 | 6845 | 0.330 |
Why?
|
Epigenesis, Genetic | 2 | 2023 | 3801 | 0.330 |
Why?
|
Residence Characteristics | 4 | 2016 | 2095 | 0.330 |
Why?
|
Insulin | 5 | 2012 | 6597 | 0.320 |
Why?
|
Social Participation | 2 | 2021 | 183 | 0.320 |
Why?
|
Diet | 10 | 2024 | 8075 | 0.320 |
Why?
|
Activities of Daily Living | 4 | 2023 | 2421 | 0.310 |
Why?
|
Health Status | 10 | 2019 | 4077 | 0.310 |
Why?
|
Educational Status | 3 | 2016 | 2522 | 0.310 |
Why?
|
Geriatric Psychiatry | 1 | 2008 | 71 | 0.310 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2006 | 1935 | 0.300 |
Why?
|
Quality of Life | 8 | 2022 | 13367 | 0.300 |
Why?
|
Mental Health | 7 | 2023 | 3250 | 0.300 |
Why?
|
Randomized Controlled Trials as Topic | 7 | 2024 | 10212 | 0.300 |
Why?
|
Peptide Fragments | 3 | 2012 | 5112 | 0.300 |
Why?
|
Folic Acid | 1 | 2015 | 1323 | 0.300 |
Why?
|
Risk Factors | 36 | 2022 | 74213 | 0.290 |
Why?
|
Interview, Psychological | 1 | 2011 | 809 | 0.290 |
Why?
|
Women's Health | 6 | 2017 | 2065 | 0.290 |
Why?
|
Longitudinal Studies | 20 | 2024 | 14608 | 0.290 |
Why?
|
United States | 34 | 2024 | 72340 | 0.290 |
Why?
|
Weight Gain | 3 | 2014 | 2348 | 0.280 |
Why?
|
Dietary Fats | 2 | 2012 | 1995 | 0.280 |
Why?
|
Self Report | 6 | 2019 | 3725 | 0.270 |
Why?
|
Male | 50 | 2024 | 360846 | 0.260 |
Why?
|
Attention | 4 | 2016 | 2396 | 0.260 |
Why?
|
Patient Compliance | 1 | 2016 | 2690 | 0.260 |
Why?
|
Exercise | 9 | 2022 | 5890 | 0.250 |
Why?
|
Cohort Studies | 20 | 2024 | 41495 | 0.250 |
Why?
|
Health Surveys | 7 | 2020 | 4061 | 0.240 |
Why?
|
Adult | 48 | 2024 | 221210 | 0.240 |
Why?
|
Citrus | 1 | 2024 | 49 | 0.240 |
Why?
|
Health Services Accessibility | 1 | 2022 | 5440 | 0.240 |
Why?
|
Pets | 1 | 2024 | 46 | 0.230 |
Why?
|
Peptic Ulcer Perforation | 1 | 2024 | 22 | 0.230 |
Why?
|
Psychotic Disorders | 1 | 2019 | 3223 | 0.230 |
Why?
|
Alcohol Drinking | 5 | 2020 | 4028 | 0.230 |
Why?
|
Stress, Psychological | 4 | 2020 | 4481 | 0.220 |
Why?
|
Linear Models | 7 | 2015 | 5872 | 0.210 |
Why?
|
Organizations | 1 | 2024 | 171 | 0.210 |
Why?
|
Ovarian Neoplasms | 5 | 2019 | 4878 | 0.210 |
Why?
|
Weight Loss | 1 | 2014 | 2684 | 0.210 |
Why?
|
Coronary Disease | 1 | 2017 | 5914 | 0.210 |
Why?
|
Anxiety Disorders | 2 | 2021 | 2720 | 0.200 |
Why?
|
Peptic Ulcer | 1 | 2024 | 217 | 0.200 |
Why?
|
Minerals | 1 | 2024 | 283 | 0.200 |
Why?
|
Suicide | 5 | 2018 | 1602 | 0.200 |
Why?
|
Comorbidity | 6 | 2020 | 10508 | 0.200 |
Why?
|
Executive Function | 2 | 2023 | 1392 | 0.190 |
Why?
|
Financing, Organized | 1 | 2023 | 204 | 0.190 |
Why?
|
Task Performance and Analysis | 1 | 2005 | 763 | 0.190 |
Why?
|
Proxy | 1 | 2022 | 151 | 0.190 |
Why?
|
Follow-Up Studies | 19 | 2017 | 39106 | 0.180 |
Why?
|
Sunbathing | 1 | 2021 | 65 | 0.180 |
Why?
|
Mothers | 3 | 2022 | 2198 | 0.180 |
Why?
|
Apolipoproteins E | 2 | 2024 | 1443 | 0.180 |
Why?
|
Aged, 80 and over | 18 | 2024 | 58984 | 0.180 |
Why?
|
Reproducibility of Results | 8 | 2019 | 20100 | 0.170 |
Why?
|
Feces | 2 | 2024 | 1497 | 0.170 |
Why?
|
Incidence | 12 | 2020 | 21355 | 0.170 |
Why?
|
Ownership | 1 | 2022 | 339 | 0.170 |
Why?
|
Marital Status | 2 | 2019 | 426 | 0.170 |
Why?
|
Logistic Models | 7 | 2019 | 13255 | 0.170 |
Why?
|
Circadian Rhythm | 2 | 2024 | 2576 | 0.170 |
Why?
|
Calcifediol | 1 | 2020 | 161 | 0.170 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2023 | 602 | 0.160 |
Why?
|
Risk | 9 | 2019 | 9610 | 0.160 |
Why?
|
Glaucoma, Open-Angle | 2 | 2016 | 738 | 0.160 |
Why?
|
Glutens | 1 | 2021 | 240 | 0.160 |
Why?
|
Adult Children | 1 | 2019 | 103 | 0.160 |
Why?
|
Diet, Vegetarian | 1 | 2020 | 180 | 0.160 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2018 | 15936 | 0.160 |
Why?
|
Chronobiology Disorders | 1 | 2019 | 73 | 0.150 |
Why?
|
Multivariate Analysis | 5 | 2016 | 12059 | 0.150 |
Why?
|
Risk Reduction Behavior | 1 | 2024 | 1112 | 0.150 |
Why?
|
Body Mass Index | 9 | 2014 | 12953 | 0.150 |
Why?
|
Focus Groups | 1 | 2024 | 1415 | 0.150 |
Why?
|
Coffee | 2 | 2013 | 593 | 0.150 |
Why?
|
Caffeine | 2 | 2013 | 700 | 0.150 |
Why?
|
Interferon-alpha | 1 | 2002 | 921 | 0.150 |
Why?
|
Photoperiod | 1 | 2018 | 139 | 0.150 |
Why?
|
Pilot Projects | 2 | 2023 | 8633 | 0.150 |
Why?
|
Fasting | 4 | 2019 | 1603 | 0.150 |
Why?
|
Time Factors | 9 | 2022 | 39969 | 0.140 |
Why?
|
Carotenoids | 1 | 2020 | 621 | 0.140 |
Why?
|
Cost of Illness | 2 | 2020 | 1937 | 0.140 |
Why?
|
Social Isolation | 1 | 2019 | 364 | 0.140 |
Why?
|
Motor Activity | 4 | 2015 | 2715 | 0.130 |
Why?
|
Health Status Disparities | 2 | 2020 | 1853 | 0.130 |
Why?
|
Genetic Markers | 1 | 2023 | 2601 | 0.130 |
Why?
|
Genetic Predisposition to Disease | 1 | 2018 | 17904 | 0.130 |
Why?
|
Antihypertensive Agents | 2 | 2016 | 2024 | 0.130 |
Why?
|
Smoking | 6 | 2017 | 9053 | 0.130 |
Why?
|
Diabetes Mellitus, Type 2 | 6 | 2016 | 12149 | 0.130 |
Why?
|
Psychology | 1 | 2018 | 356 | 0.130 |
Why?
|
Cardiovascular Diseases | 2 | 2022 | 15502 | 0.130 |
Why?
|
Morbidity | 2 | 2019 | 1752 | 0.130 |
Why?
|
Environmental Exposure | 3 | 2017 | 4485 | 0.130 |
Why?
|
Grief | 1 | 2018 | 254 | 0.130 |
Why?
|
Treatment Failure | 1 | 2021 | 2643 | 0.130 |
Why?
|
Diabetes Mellitus | 4 | 2008 | 5841 | 0.130 |
Why?
|
Fruit | 2 | 2018 | 1160 | 0.120 |
Why?
|
Vegetables | 2 | 2018 | 1195 | 0.120 |
Why?
|
Insurance Claim Review | 1 | 2020 | 741 | 0.120 |
Why?
|
Pharmacogenetics | 1 | 2019 | 675 | 0.120 |
Why?
|
Premenopause | 2 | 2017 | 1039 | 0.120 |
Why?
|
Nuts | 2 | 2014 | 264 | 0.120 |
Why?
|
Case-Control Studies | 4 | 2020 | 22176 | 0.120 |
Why?
|
Loneliness | 1 | 2016 | 203 | 0.120 |
Why?
|
Retirement | 1 | 2016 | 198 | 0.120 |
Why?
|
Aniline Compounds | 2 | 2016 | 1069 | 0.110 |
Why?
|
Trabeculectomy | 1 | 2016 | 174 | 0.110 |
Why?
|
Prolactin | 1 | 2016 | 625 | 0.110 |
Why?
|
Cause of Death | 1 | 2024 | 3683 | 0.110 |
Why?
|
Physical Endurance | 1 | 2016 | 366 | 0.110 |
Why?
|
Feasibility Studies | 1 | 2024 | 5247 | 0.110 |
Why?
|
Religion | 1 | 2016 | 372 | 0.110 |
Why?
|
Bupropion | 1 | 2015 | 304 | 0.110 |
Why?
|
Fatty Acids, Omega-6 | 1 | 2014 | 225 | 0.100 |
Why?
|
Environment | 1 | 2019 | 1123 | 0.100 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2022 | 1081 | 0.100 |
Why?
|
Health Care Surveys | 1 | 2020 | 2426 | 0.100 |
Why?
|
Cross Infection | 1 | 2021 | 1422 | 0.100 |
Why?
|
Television | 2 | 2013 | 408 | 0.100 |
Why?
|
Inflammation | 3 | 2024 | 10774 | 0.100 |
Why?
|
Paternal Age | 1 | 2012 | 87 | 0.100 |
Why?
|
Air Pollution | 2 | 2017 | 2359 | 0.100 |
Why?
|
Thiazoles | 2 | 2016 | 1517 | 0.100 |
Why?
|
Skin Neoplasms | 2 | 2021 | 5821 | 0.100 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 2014 | 344 | 0.100 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2009 | 3810 | 0.100 |
Why?
|
Gonadal Steroid Hormones | 1 | 2016 | 702 | 0.100 |
Why?
|
Least-Squares Analysis | 1 | 2012 | 369 | 0.100 |
Why?
|
Reference Values | 2 | 2010 | 4920 | 0.100 |
Why?
|
Genotype | 3 | 2024 | 12990 | 0.100 |
Why?
|
Odds Ratio | 6 | 2022 | 9647 | 0.090 |
Why?
|
Age of Onset | 3 | 2017 | 3306 | 0.090 |
Why?
|
Psychotherapy | 1 | 2020 | 1647 | 0.090 |
Why?
|
Cognitive Reserve | 1 | 2011 | 92 | 0.090 |
Why?
|
Women | 1 | 2012 | 223 | 0.090 |
Why?
|
Neoplasms | 1 | 2019 | 22173 | 0.090 |
Why?
|
Postmenopause | 2 | 2017 | 2513 | 0.090 |
Why?
|
Models, Statistical | 2 | 2015 | 5079 | 0.080 |
Why?
|
Amyloidosis | 1 | 2016 | 817 | 0.080 |
Why?
|
Eating | 2 | 2014 | 1539 | 0.080 |
Why?
|
Statistics as Topic | 3 | 2016 | 2358 | 0.080 |
Why?
|
Urinary Incontinence | 1 | 2014 | 489 | 0.080 |
Why?
|
Radioimmunoassay | 1 | 2010 | 861 | 0.080 |
Why?
|
Restless Legs Syndrome | 1 | 2012 | 233 | 0.080 |
Why?
|
Memory, Short-Term | 1 | 2015 | 982 | 0.080 |
Why?
|
Decision Making | 1 | 2022 | 3929 | 0.080 |
Why?
|
Prevalence | 5 | 2016 | 15733 | 0.080 |
Why?
|
Edetic Acid | 1 | 2009 | 276 | 0.080 |
Why?
|
Disease Progression | 3 | 2016 | 13510 | 0.080 |
Why?
|
Area Under Curve | 1 | 2012 | 1638 | 0.080 |
Why?
|
Medication Adherence | 1 | 2020 | 2176 | 0.070 |
Why?
|
ROC Curve | 2 | 2014 | 3578 | 0.070 |
Why?
|
Recurrence | 1 | 2020 | 8466 | 0.070 |
Why?
|
Income | 1 | 2016 | 1877 | 0.070 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2022 | 3246 | 0.070 |
Why?
|
Memory Disorders | 1 | 2014 | 1199 | 0.070 |
Why?
|
Psoriasis | 1 | 2015 | 950 | 0.070 |
Why?
|
Interleukin-6 | 2 | 2014 | 3208 | 0.070 |
Why?
|
Delirium | 1 | 2019 | 1668 | 0.070 |
Why?
|
Research Design | 2 | 2020 | 6180 | 0.070 |
Why?
|
Particulate Matter | 2 | 2017 | 2605 | 0.070 |
Why?
|
Pain | 2 | 2016 | 5073 | 0.070 |
Why?
|
Education | 1 | 2009 | 537 | 0.070 |
Why?
|
Social Support | 1 | 2016 | 2172 | 0.070 |
Why?
|
Obesity | 3 | 2016 | 12947 | 0.070 |
Why?
|
Lead | 1 | 2012 | 879 | 0.070 |
Why?
|
Learning | 1 | 2015 | 1740 | 0.070 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2018 | 2518 | 0.060 |
Why?
|
Patient Acceptance of Health Care | 1 | 2020 | 3206 | 0.060 |
Why?
|
Overweight | 2 | 2014 | 2417 | 0.060 |
Why?
|
C-Reactive Protein | 2 | 2014 | 3826 | 0.060 |
Why?
|
Pregnancy | 4 | 2020 | 29890 | 0.060 |
Why?
|
Sickness Impact Profile | 2 | 2016 | 299 | 0.060 |
Why?
|
Drug Therapy, Combination | 1 | 2015 | 6312 | 0.060 |
Why?
|
Saliva | 2 | 2019 | 828 | 0.060 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2006 | 416 | 0.060 |
Why?
|
Monoamine Oxidase | 1 | 2024 | 181 | 0.060 |
Why?
|
Databases, Factual | 1 | 2020 | 7968 | 0.060 |
Why?
|
Melanoma | 1 | 2002 | 5709 | 0.050 |
Why?
|
S-Adenosylmethionine | 1 | 2024 | 218 | 0.050 |
Why?
|
Telephone | 1 | 2006 | 627 | 0.050 |
Why?
|
Positron-Emission Tomography | 2 | 2016 | 6484 | 0.050 |
Why?
|
Air Pollutants | 1 | 2017 | 2896 | 0.050 |
Why?
|
Vision, Low | 1 | 2005 | 163 | 0.050 |
Why?
|
Sex Distribution | 1 | 2008 | 2280 | 0.050 |
Why?
|
Central Nervous System Stimulants | 1 | 2011 | 1177 | 0.050 |
Why?
|
Single-Blind Method | 1 | 2006 | 1574 | 0.050 |
Why?
|
Longevity | 1 | 2010 | 1065 | 0.050 |
Why?
|
Biological Clocks | 1 | 2024 | 318 | 0.050 |
Why?
|
beta Carotene | 1 | 2023 | 523 | 0.050 |
Why?
|
Medicare | 1 | 2020 | 6770 | 0.050 |
Why?
|
Object Attachment | 1 | 2024 | 326 | 0.050 |
Why?
|
Laparotomy | 1 | 2024 | 457 | 0.050 |
Why?
|
Heparin | 1 | 2009 | 1634 | 0.050 |
Why?
|
Academies and Institutes | 1 | 2023 | 318 | 0.050 |
Why?
|
Algorithms | 2 | 2012 | 14033 | 0.050 |
Why?
|
Regression Analysis | 2 | 2013 | 6345 | 0.050 |
Why?
|
Metagenomics | 1 | 2024 | 467 | 0.050 |
Why?
|
Animals | 8 | 2024 | 168475 | 0.040 |
Why?
|
Cerebral Cortex | 1 | 2016 | 5779 | 0.040 |
Why?
|
Fishes | 2 | 2014 | 603 | 0.040 |
Why?
|
Divorce | 1 | 2019 | 75 | 0.040 |
Why?
|
Netherlands | 1 | 2024 | 2221 | 0.040 |
Why?
|
Widowhood | 1 | 2019 | 51 | 0.040 |
Why?
|
alpha-Amylases | 1 | 2019 | 39 | 0.040 |
Why?
|
Hostility | 1 | 2020 | 183 | 0.040 |
Why?
|
Adiposity | 1 | 2009 | 1879 | 0.040 |
Why?
|
Predictive Value of Tests | 2 | 2012 | 15266 | 0.040 |
Why?
|
Stroke | 2 | 2011 | 9758 | 0.040 |
Why?
|
Hypertension | 2 | 2016 | 8540 | 0.040 |
Why?
|
Canada | 1 | 2024 | 2122 | 0.040 |
Why?
|
Dogs | 1 | 2024 | 3839 | 0.040 |
Why?
|
Nutritional Status | 2 | 2020 | 1615 | 0.040 |
Why?
|
Survivors | 1 | 2009 | 2371 | 0.040 |
Why?
|
Intergenerational Relations | 1 | 2019 | 67 | 0.040 |
Why?
|
Genome-Wide Association Study | 1 | 2018 | 12690 | 0.040 |
Why?
|
Psychological Tests | 2 | 2012 | 640 | 0.040 |
Why?
|
Sensitivity and Specificity | 2 | 2014 | 14665 | 0.040 |
Why?
|
Fish Oils | 1 | 2021 | 483 | 0.040 |
Why?
|
Mortality | 2 | 2024 | 2902 | 0.040 |
Why?
|
Mentors | 1 | 2023 | 661 | 0.040 |
Why?
|
Brain Ischemia | 1 | 2011 | 3049 | 0.040 |
Why?
|
Mental Recall | 2 | 2014 | 1221 | 0.040 |
Why?
|
Infusions, Intravenous | 1 | 2002 | 2217 | 0.040 |
Why?
|
Nails | 1 | 2019 | 296 | 0.040 |
Why?
|
Delivery of Health Care | 1 | 2015 | 5337 | 0.030 |
Why?
|
Confidence Intervals | 2 | 2013 | 2927 | 0.030 |
Why?
|
Electroconvulsive Therapy | 1 | 2002 | 500 | 0.030 |
Why?
|
Walking | 1 | 2024 | 1198 | 0.030 |
Why?
|
Ultraviolet Rays | 1 | 2021 | 1080 | 0.030 |
Why?
|
Young Adult | 5 | 2022 | 59260 | 0.030 |
Why?
|
Trabecular Meshwork | 1 | 2016 | 101 | 0.030 |
Why?
|
Pregnancy Trimester, Second | 1 | 2018 | 731 | 0.030 |
Why?
|
Hair | 1 | 2019 | 498 | 0.030 |
Why?
|
Tonometry, Ocular | 1 | 2016 | 235 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2021 | 846 | 0.030 |
Why?
|
Angina, Unstable | 1 | 2019 | 888 | 0.030 |
Why?
|
Diagnostic Self Evaluation | 1 | 2015 | 224 | 0.030 |
Why?
|
Ozone | 1 | 2017 | 483 | 0.030 |
Why?
|
Parietal Lobe | 1 | 1998 | 852 | 0.030 |
Why?
|
Academic Medical Centers | 1 | 2024 | 2759 | 0.030 |
Why?
|
Anticoagulants | 1 | 2009 | 4812 | 0.030 |
Why?
|
Epidemiologic Studies | 1 | 2016 | 675 | 0.030 |
Why?
|
Cholesterol, LDL | 1 | 2022 | 2382 | 0.030 |
Why?
|
Meat Products | 1 | 2013 | 96 | 0.030 |
Why?
|
Emotions | 1 | 2024 | 2739 | 0.030 |
Why?
|
Health Behavior | 2 | 2017 | 2644 | 0.030 |
Why?
|
Recombinant Proteins | 1 | 2002 | 6534 | 0.030 |
Why?
|
Socioeconomic Factors | 2 | 2017 | 7828 | 0.020 |
Why?
|
Drug Utilization Review | 1 | 2013 | 248 | 0.020 |
Why?
|
Databases, Bibliographic | 1 | 2012 | 130 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2015 | 945 | 0.020 |
Why?
|
Verbal Learning | 1 | 2014 | 463 | 0.020 |
Why?
|
Spectrometry, X-Ray Emission | 1 | 2012 | 143 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2018 | 64685 | 0.020 |
Why?
|
Maternal Exposure | 1 | 2018 | 1067 | 0.020 |
Why?
|
Hydrocortisone | 1 | 2019 | 1819 | 0.020 |
Why?
|
Phenotype | 1 | 2009 | 16592 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2016 | 1186 | 0.020 |
Why?
|
Outpatients | 1 | 2019 | 1597 | 0.020 |
Why?
|
Age Factors | 2 | 2021 | 18399 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2017 | 21019 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2024 | 3744 | 0.020 |
Why?
|
Mother-Child Relations | 1 | 2014 | 495 | 0.020 |
Why?
|
Health Personnel | 1 | 2024 | 3335 | 0.020 |
Why?
|
Length of Stay | 1 | 2024 | 6426 | 0.020 |
Why?
|
Intraocular Pressure | 1 | 2016 | 1294 | 0.020 |
Why?
|
Meat | 1 | 2013 | 584 | 0.020 |
Why?
|
Health Occupations | 1 | 2011 | 222 | 0.020 |
Why?
|
Developed Countries | 1 | 2012 | 449 | 0.020 |
Why?
|
Laser Therapy | 1 | 2016 | 1092 | 0.020 |
Why?
|
Cerebrovascular Circulation | 1 | 1998 | 2727 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2019 | 2922 | 0.020 |
Why?
|
Hospitals | 1 | 2021 | 3883 | 0.020 |
Why?
|
Adolescent | 3 | 2022 | 88326 | 0.020 |
Why?
|
Sleep | 1 | 2024 | 4768 | 0.020 |
Why?
|
Preventive Health Services | 1 | 2012 | 567 | 0.020 |
Why?
|
Geriatric Assessment | 1 | 2015 | 1410 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2016 | 15843 | 0.020 |
Why?
|
Chronic Disease | 2 | 2013 | 9319 | 0.020 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2015 | 2009 | 0.020 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2009 | 540 | 0.020 |
Why?
|
Parents | 1 | 2020 | 3563 | 0.020 |
Why?
|
Population Surveillance | 1 | 2016 | 2598 | 0.020 |
Why?
|
Estrogen Replacement Therapy | 1 | 2012 | 1208 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2014 | 1886 | 0.020 |
Why?
|
Massachusetts | 1 | 2017 | 8833 | 0.010 |
Why?
|
Vitamin E | 1 | 2009 | 872 | 0.010 |
Why?
|
Menopause | 1 | 2012 | 1646 | 0.010 |
Why?
|
Alcoholism | 1 | 2014 | 1973 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2013 | 6815 | 0.010 |
Why?
|
Child | 2 | 2022 | 80158 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10766 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2005 | 11122 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2013 | 4352 | 0.010 |
Why?
|
Hippocampus | 1 | 2015 | 3766 | 0.010 |
Why?
|
Sex Factors | 1 | 2016 | 10554 | 0.010 |
Why?
|
Pandemics | 1 | 2021 | 8656 | 0.010 |
Why?
|
Bone and Bones | 1 | 2012 | 2568 | 0.010 |
Why?
|
Fatty Acids | 1 | 2009 | 1808 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2024 | 80647 | 0.010 |
Why?
|
Blood Pressure | 1 | 2016 | 8481 | 0.010 |
Why?
|
Developing Countries | 1 | 2012 | 2885 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2019 | 26202 | 0.010 |
Why?
|
Public Health | 1 | 2012 | 2669 | 0.010 |
Why?
|
Models, Biological | 1 | 2015 | 9469 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2010 | 2882 | 0.010 |
Why?
|
Infant | 1 | 2019 | 36193 | 0.010 |
Why?
|
Survival Analysis | 1 | 2009 | 10090 | 0.010 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 1998 | 1068 | 0.010 |
Why?
|
Risk Assessment | 1 | 2012 | 23996 | 0.010 |
Why?
|
Analysis of Variance | 1 | 1998 | 6228 | 0.010 |
Why?
|
Mice | 1 | 2016 | 81539 | 0.000 |
Why?
|
Alleles | 1 | 1998 | 6864 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2015 | 36426 | 0.000 |
Why?
|
Brain Mapping | 1 | 1998 | 6635 | 0.000 |
Why?
|